Latest Articles
- Phenylpropanolamine and stroke: The study, the FDA ruling, the implications
The FDA, after a recent study, asked manufacturers to pull dozens of products from the shelves.
- Making the most of cholesterol-lowering margarines
These new “functional foods” reduce serum cholesterol and LDL levels modestly when used instead of regular margarine, butter, or oil. Are they worth it?
- Rare but serious adverse effects in commonly used drugs
Some adverse effects come to light only after millions of people have taken a drug.
- New findings in multiple sclerosis: A message for primary care clinicians
Every once in a while, a new finding transforms the diagnosis and treatment of a disease.
- Strategies to prevent progression of renal disease
Reviewing current theories of how renal disease develops and progresses and how to prevent or slow the process.
- A lung-transplant recipient with infiltrates
Questions and answers on the visible signs of diseases.
- Changing patterns of morbidity and mortality in HIV disease
With the success of highly active antiretroviral therapy (HAART) come new problems.
- The Mustt Trial
Implantable defibrillators, but not antiarrhythmic drugs reduce the mortality rate in MI survivors at high risk.